These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material? Hoffmann U, Fischereder M, Marx M, Schweda F, Lang B, Straub RH, Krämer BK. Am J Nephrol; 2003; 23(6):442-7. PubMed ID: 14583663 [Abstract] [Full Text] [Related]
6. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes. Degiannis D, Czarnecki M, Donati D, Homer L, Eisinger RP, Raska K, Raskova J. Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054 [Abstract] [Full Text] [Related]
7. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? Mrowka C, Heintz B, Sieberth HG. Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995 [Abstract] [Full Text] [Related]
8. Soluble P-selectin is released from activated platelets in vivo during hemodialysis. Kawabata K, Nagake Y, Shikata K, Fukuda S, Nakazono H, Takahashi M, Ichikawa H, Makino H. Nephron; 1998 Nov; 78(2):148-55. PubMed ID: 9496730 [Abstract] [Full Text] [Related]
9. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients. Petersen J, Moore RM, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M. Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659 [Abstract] [Full Text] [Related]
10. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane. Sirolli V, Ballone E, Di Stante S, Amoroso L, Bonomini M. Int J Artif Organs; 2002 Jun; 25(6):529-37. PubMed ID: 12117292 [Abstract] [Full Text] [Related]
11. Clinical characterization of Dicea a new cellulose membrane for haemodialysis. Hoenich NA, Woffindin C, Cox PJ, Goldfinch M, Roberts SJ. Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161 [Abstract] [Full Text] [Related]
16. C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes. Panichi V, Rizza GM, Taccola D, Paoletti S, Mantuano E, Migliori M, Frangioni S, Filippi C, Carpi A. Biomed Pharmacother; 2006 Jan; 60(1):14-7. PubMed ID: 16330177 [Abstract] [Full Text] [Related]
17. Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone. Amato M, Salvadori M, Bergesio F, Messeri A, Filimberti E, Morfini M. Int J Artif Organs; 1988 May; 11(3):175-80. PubMed ID: 3261279 [Abstract] [Full Text] [Related]
18. In vivo evaluation of platelet activation by different cellulosic membranes. Cases A, Reverter JC, Escolar G, Sanz C, Sorribes J, Ordinas A. Artif Organs; 1997 Apr; 21(4):330-4. PubMed ID: 9096808 [Abstract] [Full Text] [Related]
19. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P. J Immunol; 1995 Jan 15; 154(2):882-92. PubMed ID: 7814891 [Abstract] [Full Text] [Related]